UFC releases statement on Nick Diaz’s UFC 183 post-fight positive drug test

image via UFC

Earlier this evening, the UFC released a statement concerning Anderson Silva’s failed UFC 183 pre-fight drug test for an anabolic steroid. They followed just hours later with a statement on his opponent, Nick Diaz, failing his post-fight drug test.

The UFC has been notified by the Nevada State Athletic Commission that Nick Diaz has tested positive for marijuana metabolites following his fight with Anderson Silva at UFC 183 on Jan. 31 in Las Vegas, Nev. The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by our athletes. As a result of his positive test, Diaz has been informed that he has violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC organization will fully respect the Commission’s final decision relating to Diaz at a disciplinary hearing set for February 17.

For Silva, this is the first time he’s tested positive for a banned substance during his storied mixed martial arts career. For Diaz, this would be his third time testing positive for marijuana. His historic Gogoplata submission victory over Takanori Gomi was overturned back in 2007 at PRIDE 33. His second “offense” would come in 2013 following his loss against Carlos Condit back at UFC 143. Diaz would be suspended for a year and would be forced to forfeit 30% of his purse to Condit.

Stay tuned for much on this story in the days and weeks to come.